Beth LeBow
Lawyers
Advises issuers and financial institutions on a variety of capital markets transactions, including IPOs and other equity and debt offerings.
Beth advises issuers and underwriters on capital markets transactions, including initial public offerings and other equity offerings, private placements, and debt and convertible debt offerings. She also provides advice to clients on public reporting, securities compliance and corporate governance matters.
Beth has experience across a wide variety of industries, with a particular focus on healthcare and life sciences and on technology.
Experience highlights
Recent Representations
- Reddit $748 million IPO
- RayzeBio $358 million IPO
- CSG Systems International $425 million convertible senior notes offering
- ACELYRIN $621 million IPO
- Enovix $162.5 million convertible senior notes and capped call transactions
- Revolution Medicines $345 million follow-on offering
- Tenaya Therapeutics $75 million stock and pre-funded warrants offering
- Natera $400 million follow-on offering
- Elon Musk $13.2 billion Twitter acquisition financing
- IDEAYA Biosciences $92 million follow-on offering
- Tenaya Therapeutics $75 million at-the-market offering
- RxSight $50 million at-the-market offering
- Cryoport $403 million notes offering and concurrent $249 million stock offering
- Aligos Therapeutics $75 million at-the-market offering
- ForgeRock $316 million IPO
- Ingram Micro $7.2 billion acquisition by Platinum Equity
Education
J.D., Stanford Law School
- Editor, Stanford Law Review
B.S., Animal Science, Cornell University
- summa cum laude
- with distinction in research
Professional history
- Counsel, 2024-present
- Davis Polk since 2017
Qualifications and admissions
- State of California